Japanese Journal of Clinical Oncology · 2016 · 17 citations · 20 references
MedicineNutritionOncologyPalliative CarePalliative MedicinePalliative OncologyHealth-related Quality Of LifeNutrition During Cancer CareOncology NutritionQuality Of LifeSupportive Care In CancerSurvival OutcomesCancer-related Quality Of LifeFunctional Status MonitoringHospital Stay DurationNasogastric Tube FeedingNasogastric Tube PlacementNutritional Assessment In CancerObservational Study EvaluationPatient-reported Functional Status
BACKGROUND: Little is known about quality of life and functional status of patients with terminally ill head and neck cancers. METHODS: We conducted a multicenter, prospective, observational study to examine quality of life and functional status in terminally ill head and neck cancer patients. RESULTS: Of the 100 patients meeting inclusion criteria, 72 were observed until death. There was no significant difference in the quality of life score between baseline and Week 3. Forty patients (54.9%) could speak and 22 patients (30.5%) could have oral intake upon study entry. Fifty-three patients (74.6%) received enteral nutrition. Twenty-six patients (36.6%) required dressing changes for fungating tumors. The route of nutritional intake (nasogastric tube vs. percutaneous gastric tube) might be predictive for the duration of hospital stay (64 vs. 21 days, P = 0.0372). CONCLUSION: There was no significant relationship between quality of life and functional status seen in this study. Feeding tube type could have the most impact on quality of life.
20
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer · 2010 · 21.4K citations
N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman et al. · JNCI Journal of the National Cancer Institute · 1993 · 16K citations
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
James A. Bonner, Paul M. Harari, J. Giralt et al. · New England Journal of Medicine · 2006 · 5.1K citations · Full text
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Jan B. Vermorken, Fernando Rivera, Éva Remenár et al. · New England Journal of Medicine · 2008 · 3.7K citations · Full text
Medicine, Oncology, Pharmacology +16
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
Jan B. Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text